Consultant Clinical Scientist

Our client, FoRx Therapeutics, is a privately‑held company aiming to develop first‑in‑class compounds for cancer treatment.

FoRx focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.

The Consultant Clinical Scientist will play a key role in the data oversight of an early‑phase oncology clinical trial. This position will support the CMO and Medical Lead for data review (safety, efficacy, biomarker, PK), ensuring consistency, medical integrity, and quality of the clinical trial data. The ideal candidate has a strong scientific background, knowledge of oncology drug development, and hands‑on experience in Phase I clinical trials.

• Support the CMO and Medical Lead Serve for data review and issue resolution.
• Support the CMO and Medical Lead in clinical trial execution, ensuring alignment with protocol, safety oversight, and data quality.
• Participate in the development and review of clinical documents, including protocols, amendments, ICFs, CRFs, and clinical study reports (CSRs).
• Participate in data review activities, including safety data review, line‑listings, and review of clinical listings and narratives.
• Support clinical data cleaning in collaboration with the CRO.
• Prepare and contribute to clinical content for regulatory submissions (e.g., IBs, DSURs, IND safety reports).
• Provide scientific input into safety review committees, dose escalation meetings, and other study team forums.
• Collaborate cross‑functionally with the FoRx clinical team and other personal

• Advanced degree (PhD, Pharm
  
  D, MD, or equivalent) in life sciences or a clinical discipline.
• Minimum 7 years of experience in clinical development, with at least 3-4 years in early‑phase oncology trials.
• Deep understanding of clinical trial processes, GCP, ICH E6(R2), and regulatory frameworks.
• Experience with data review and cleaning, including working with EDC platforms, listings, and query resolution.
• Strong knowledge of oncology endpoints, dose escalation methods, and Phase I safety assessment.
• Excellent interpersonal and communication skills for cross‑functional collaboration and external CRO interface.
• Ability to analyze and interpret clinical data, recognize trends, and escalation safety or efficacy concerns.
• Experience in first‑in‑human (FIH) or dose‑escalation oncology trials.
• Prior work with external CROs or in biotech/pharma sponsor organizations.
• Familiarity with ePRO, biomarker data, and PK/PD integration.
• Scientific curiosity, initiative, and a solution‑oriented mindset.
• Highly organized with attention to detail and ability to manage competing priorities.
• Strong written and verbal English communication skills.

The workplace is in Basel with no possibility for remote work. EU/Swiss work permit is strongly required.